{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:33:02Z","timestamp":1761561182297,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ahj.2007.06.023","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T08:56:51Z","timestamp":1187686611000},"page":"695-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents"],"prefix":"10.1016","volume":"154","author":[{"given":"Dmitriy N.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Chiu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Gade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Gidseg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Minutello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2007.06.023_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo-controlled and balloon-angioplasty\u2013controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb\/IIIa blockade","volume":"352","author":"EPISTENT Investigators","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2007.06.023_bib2","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial","volume":"356","author":"ESPRIT Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2007.06.023_bib3","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199509213331204","article-title":"Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina","volume":"333","author":"Bittl","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.06.023_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mhj.2001.119374","article-title":"Bivalirudin versus heparin during coronary angioplasty for unstable or post-infarction angina: final report reanalysis of the Bivalirudin Angioplasty Study","volume":"142","author":"Bittl","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2007.06.023_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1527-3466.2005.tb00177.x","article-title":"Bivalirudin: pharmacology and clinical applications","volume":"23","author":"Shammas","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.ahj.2007.06.023_bib6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjcard.2004.01.033","article-title":"Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)","volume":"93","author":"Lincoff","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2007.06.023_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/107424840501000401","article-title":"Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis","volume":"10","author":"Ebrahimi","year":"2005","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ahj.2007.06.023_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.amjcard.2004.11.021","article-title":"Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center","volume":"95","author":"Gurm","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2007.06.023_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(07)60450-4","article-title":"Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial","volume":"369","author":"Stone","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2007.06.023_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.amjcard.2005.04.039","article-title":"Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study)","volume":"96","author":"Dangas","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.amjcard.2004.06.065","article-title":"Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent","volume":"94","author":"Rha","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib14","first-page":"70","article-title":"Safety and feasibility of bivalirudin with either Cypher or TAXUS drug-eluting stent during percutaneous coronary intervention","volume":"1","author":"Chieffo","year":"2005","journal-title":"Eurointervention"},{"key":"10.1016\/j.ahj.2007.06.023_bib15","first-page":"63","article-title":"Bivalirudin versus heparin plus glycoprotein IIb\/IIIa inhibitors in drug-eluting stent implantations in the absence of acute myocardial infarction: clinical and economic results","volume":"19","author":"Mishkel","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/aje\/152.2.107","article-title":"Comparison of National Death Index and World Wide Web death searches","volume":"152","author":"Sesso","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2007.06.023_bib18","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/01.CIR.90.3.1522","article-title":"Direct thrombin inhibitors in cardiovascular medicine","volume":"90","author":"Lefkovits","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.06.023_bib19","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1021\/bi00253a020","article-title":"Kinetic mechanism for the interaction of Hirulog with thrombin","volume":"33","author":"Parry","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.ahj.2007.06.023_bib20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib21","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"10.1016\/j.ahj.2007.06.023_bib22","first-page":"10B","article-title":"A prospective, randomized trial of bivalirudin in acute coronary syndromes: one year results from the ACUITY trial","volume":"49","author":"Stone","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2007.06.023_bib23","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1161\/01.CIR.98.24.2695","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction","volume":"98","author":"Neumann","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.06.023_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/s-0038-1657620","article-title":"GPIIb\/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab","volume":"78","author":"Coller","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2007.06.023_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(02)01145-2","article-title":"Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization","volume":"113","author":"Topol","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2007.06.023_bib26","first-page":"1194","article-title":"Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb\/IIIa blockade compared to heparin with routine glycoprotein IIb\/IIIa blockade: a REPLACE-2 substudy","volume":"44","author":"Saw","year":"2004","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307005261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870307005261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:33:29Z","timestamp":1757568809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870307005261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0002870307005261"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2007.06.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2007.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}